Patient Access & Support
How to get your patients started on
Together with your patient, complete the Start Form to initiate verification of benefits and eligibility assessment for financial assistance if required.
Alnylam Assist® provides personalized support for patients prescribed GIVLAARI. Alnylam Assist® can explain the requirements and processes for prior authorizations, claims, and appeals.
Financial Assistance Programs
Alnylam Assist® offers various options to help patients who need additional assistance:
Copay Assistance†: Covers out-of-pocket costs for eligible patients
Quick Start: Provides up to 3 doses of GIVLAARI at no cost to eligible patients if coverage is delayed due
to prior authorization
Patient Assistance Program†: Provides GIVLAARI at no cost to eligible patients
*Coverage may vary for individual and plan. Data as of February 2021.
†Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue the program at any time.
Help your patients get started with
GIVLAARI® (givosiran) with Alnylam Assist®
Fill out the start form available below—this will help your patient access personalized support and benefits that Alnylam Assist® offers—with benefit verification notification in 1-2 business days. Want to learn more about Alnylam Assist® and the Start Form? Contact your local rep here.
What happens next:
Alnylam Assist® provides personalized support for your patients throughout the treatment process
A dedicated Case Manager
Alnylam Assist® will connect patients with a dedicated Alnylam Assist® Case Manager who can provide personalized support throughout the GIVLAARI® (givosiran) treatment process.
Coverage for GIVLAARI will vary by plan and by patient. Alnylam Assist® can help determine patient-specific coverage requirements.
Eligible patients* may qualify for the Alnylam Assist® Quick Start Program, Patient Assistance Program, or Commercial Copay Program.
Disease and product education
Patient Education Liaisons (PELs) are available to help educate patients and their families on acute hepatic porphyria and GIVLAARI.
Field Reimbursement Directors (FRDs)
Alnylam Assist® support team members are located across the country—local FRDs can meet with HCPs and staff to educate on GIVLAARI access and reimbursement, including the prior authorization process and requirements, claims, and appeals in the case of a denial. They can also help explain billing and coding, chart documentation, and payer requirements for GIVLAARI.
*Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue the program at any time.